Aktiespot

Nanosonics Limited (Nanosonics Ltd.) Aktie

NNCSF

$2.5500+0.0500 (+2.00%)
Chart wird geladen...

Nanosonics Ltd.

Eröffnung2.5500
Hoch2.5500
Tief2.5500
Volumen400
P/E51.00
Marktkapitalisierung761.99M
52-Wochen-Hoch3.0575
52-Wochen-Tief2.1600
Durchschn. Volumen125
DividendeN/A
Beta1.21
EPS0.0500

Über Nanosonics Limited (Nanosonics Ltd.) Aktie

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It also provides trophon2 a device with an enhanced design and new functionality, including AcuTrace TM for audit-ready digital record-keeping and capabilities to connect trophon 2 with hospital IT systems; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. Nanosonics Limited was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Unternehmensinformationen

Börse: OTC Markets OTCPK (PNK)
Sektor: Sundhed
Branche: Medicinske instrumenter og forbrugsvarer
Adresse:
Building A
2113 Macquarie Park, Australia
Telefon: + 61 2 8063 1600

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: